Paradoxical plaque psoriasis due to secukinumab treatment in an ankylosing spondylitis patient

Dermatol Ther. 2020 Jul;33(4):e13504. doi: 10.1111/dth.13504. Epub 2020 Jun 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Humans
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Spondylitis, Ankylosing* / diagnosis
  • Spondylitis, Ankylosing* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab